Top Markets
Coin of the day
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rang in aandelen #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Aandeelprijs
$9.13
Marktkapitalisatie
$39.27K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-11.76%
Land
IE
Handel Malin Corporation plc (MLC)

Categorie

EPS voor Malin Corporation plc (MLC)
EPS per December 2025 TTM: $-0.80
Volgens de laatste financiële rapporten en de aandelenkoers van Malin Corporation plc is de huidige EPS van het bedrijf (TTM) $-0.80. Eind 2023 had het bedrijf een EPS van 0.00, een stijging ten opzichte van de EPS van 2022 die $0.41 bedroeg.
EPS-geschiedenis van Malin Corporation plc van 2015 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.80 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 $0.41 450.07%
2021 $0.07 -96.81%
2020 $2.33 -1,985.01%
2019 $-0.12 -89.37%
2018 $-1.16 -59.02%
2017 $-2.83 26.95%
2016 $-2.23 26.03%
2015 $-1.77 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$1.57 -297.07%
FR
$7.03 -980.91%
DE
$0.23 -129.34%
JP
$6.03 -855.83%
US
$0.51 -163.44%
IN